PMC:7029759 / 36554-36826 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"957","span":{"begin":17,"end":39},"obj":"Species"},{"id":"958","span":{"begin":259,"end":267},"obj":"Species"},{"id":"960","span":{"begin":5,"end":9},"obj":"Disease"}],"attributes":[{"id":"A957","pred":"tao:has_database_id","subj":"957","obj":"Tax:277944"},{"id":"A958","pred":"tao:has_database_id","subj":"958","obj":"Tax:9606"},{"id":"A960","pred":"tao:has_database_id","subj":"960","obj":"MESH:D045169"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n of SARS versus human coronavirus NL63 65. Lastly, scaling the dose of any effective vaccine would also prove to be challenging depending on the vector format (e.g. viral vector versus mRNA versus protein), and even a fully protective vaccine would not help patients who "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T666","span":{"begin":5,"end":9},"obj":"SP_10"},{"id":"T665","span":{"begin":17,"end":22},"obj":"SP_6;NCBITaxon:9606"},{"id":"T664","span":{"begin":23,"end":34},"obj":"NCBITaxon:11118"},{"id":"T663","span":{"begin":146,"end":152},"obj":"SO:0000440"},{"id":"T662","span":{"begin":166,"end":171},"obj":"NCBITaxon:10239"},{"id":"T661","span":{"begin":172,"end":178},"obj":"SO:0000440"}],"text":"n of SARS versus human coronavirus NL63 65. Lastly, scaling the dose of any effective vaccine would also prove to be challenging depending on the vector format (e.g. viral vector versus mRNA versus protein), and even a fully protective vaccine would not help patients who "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T227","span":{"begin":186,"end":190},"obj":"Body_part"},{"id":"T228","span":{"begin":198,"end":205},"obj":"Body_part"}],"attributes":[{"id":"A227","pred":"fma_id","subj":"T227","obj":"http://purl.org/sig/ont/fma/fma67122"},{"id":"A228","pred":"fma_id","subj":"T228","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"n of SARS versus human coronavirus NL63 65. Lastly, scaling the dose of any effective vaccine would also prove to be challenging depending on the vector format (e.g. viral vector versus mRNA versus protein), and even a fully protective vaccine would not help patients who "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T124","span":{"begin":5,"end":9},"obj":"Disease"}],"attributes":[{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"n of SARS versus human coronavirus NL63 65. Lastly, scaling the dose of any effective vaccine would also prove to be challenging depending on the vector format (e.g. viral vector versus mRNA versus protein), and even a fully protective vaccine would not help patients who "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T375","span":{"begin":17,"end":22},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T376","span":{"begin":217,"end":218},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"n of SARS versus human coronavirus NL63 65. Lastly, scaling the dose of any effective vaccine would also prove to be challenging depending on the vector format (e.g. viral vector versus mRNA versus protein), and even a fully protective vaccine would not help patients who "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T160","span":{"begin":198,"end":205},"obj":"Chemical"}],"attributes":[{"id":"A160","pred":"chebi_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"n of SARS versus human coronavirus NL63 65. Lastly, scaling the dose of any effective vaccine would also prove to be challenging depending on the vector format (e.g. viral vector versus mRNA versus protein), and even a fully protective vaccine would not help patients who "}